# Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke

> **NCT01661322** · PHASE3 · TERMINATED · sponsor: **University of Nottingham** · enrollment: 3096 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Aspirin, Dipyradimole, Clopidogrel

## Key facts

- **NCT ID:** NCT01661322
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 3096 (ACTUAL)
- **Why stopped:** Trial reached a definitive answer ahead of full recruitment.
- **Last updated:** 2018-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01661322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01661322, "Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01661322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*